Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers
Titel:
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers
Auteur:
Borcoman, Edith Lalanne, Ana Delord, Jean-Pierre Cassier, Philippe A. Rolland, Frédéric Salas, Sébastien Limacher, Jean-Marc Capitain, Olivier Lantz, Olivier Ekwegbara, Christina Jeannot, Emmanuelle Cyrta, Joanna Tran-Perennou, Carine Castel-Ajgal, Zahra Marret, Grégoire Piaggio, Eliane Brandely, Maud Tavernaro, Annette Makhloufi, Hakim Bendjama, Kaidre Le Tourneau, Christophe